Professor of Medicine, Northwestern University
Oncology
Dr. Janardan D. Khandekar, MD
|
|
Give Review
Janardan Khandekar practices Oncology. He studied medicine at M.G.M. Medical College. He received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Whos Who in Medicine and Healthcare". Janardan D. Khandekar, MD has written publications. He has 63 publications published with PubMed. The lastest paper is: 'Common terms in molecular biology--Part 3 (r-z).' Janardan D. Khandekar, MD is registered with Medicare.
Publications
- Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit.
- Value of Personalized Medicine.
- Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.
- Biomarkers for the early detection of cancer: an inflammatory concept.
- Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma.
- Residency training in the modern era: the pipe dream of less time to learn more, care better, and be more professional.
- Direct observation of genomic heterogeneity through local haplotyping analysis.
- Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study.
- Phase II study of spirogermanium in advanced breast cancer.
- Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
- Thyroid hormone administration in irradiated patients.
- Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
- Causes and evaluation of tumor-induced hypoglycemia.
- Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
- Common terms in molecular biology--Part 3 (r-z).
- Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
- Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients.
- A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract.
- Recurrence in patients on adjuvant chemotherapy for breast cancer.
- A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments.
- Neurologic involvement in glucagonoma syndrome: response to combination chemotherapy with 5-fluorouracil and streptozotocin.
- Carcinoma in a heterotopically auto-implanted nipple.
- Studies of amygdalin (laetrile) toxicity in rodents.
- Hepatic fine structural changes and microsomal hypofunction in Walker tumor-bearing rats.
- Preoperative and follow-up procedures on patients with breast cancer.
- Urinary bladder metastases from breast carcinoma.
- Amygdalin (laetrile) toxicity in rodents.
- Metastatic basal cell carcinoma.
- A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
- Acute erythroleukemia complicating prolonged chemotherapy for ovarian carcinoma.
- A method for the quantitative analysis of human heat shock gene expression using a multiplex RT-PCR assay.
- Recommendations on follow-up of breast cancer patients following primary therapy.
- Achieving local control for inflammatory carcinoma of the breast.
- Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients.
- Delayed recurrences in primary fallopian tube carcinoma.
- Magnetic-induction hyperthermia. Results of a 5-year multi-institutional national cooperative trial in advanced cancer patients.
- A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic gliom...
- A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
- Adjuvant chemotherapy for stage II and III breast carcinoma.
- Symptomatology as an indicator of recurrent or metastatic breast cancer.
- Parietal pleurectomy for malignant pleural effusion.
- Extragonadal seminoma involving urinary bladder and arising in the prostate.
- Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
- Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.
- Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
- Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
- Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases.
- Current status: evaluation of dietary fat reduction as secondary breast cancer prevention. The Nutrition Adjuvant Study.
- Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study.
- High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.
- The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer.
- Association of nonmelanoma skin cancer with second malignancy.
- Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women''s Health Initiative Randomized Trial.
- Phase 1 clinical trials: not just for safety anymore?
- Evolving molecular-based targeted therapy for cancer: an exciting field.
- Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study.
- Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
- Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk.
- Effect of an electronic health record on the culture of an outpatient medical oncology practice in a four-hospital integrated health care system: 5-year experience.
- Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system.
- The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
- Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.
Schools
MGM Medical College
MY Hospital
Allegheny General Hospital
Tufts University Hosps
Procedures Preformed
- Thoracentesis
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Whos Who in Medicine and Healthcare
Education
-
Tufts Medical Center -
Allegheny General Hospital - Western Pennsylvania Hospital -
M.G.M. Medical College
Hospital
-
NorthShore University Health System -
NorthShore Skokie Hospital
Drug Facts
| NPI NUMBER | 1851324503 | |
| NPPES Provider LastName | KHANDEKAR | |
| NPPES Provider FirstName | JANARDAN | |
| NPPES Provider ZIPCode | 602011718 | |
| NPPES Provider State | IL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 174.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851324503 |
| Last Name Of The Provider | KHANDEKAR |
| First Name Of The Provider | JANARDAN |
| View All |
Similar Doctors
|
Dr. Keith I. Block, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Elizabeth King K. Woo-Strauss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arjun D. Mehta, MD |
|
Dr. Bruce E. Brockstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tina A. Fabiano, DO |
|
|
Dr. Sara E. Barnato, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Teresa A. Murray Law, MD
This Doctor is OpenDoctor Recommended.
|